Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

16260 Ventura Blvd., Suite 140
Encino, CA 91436
Phone: 818-528-7776

May 14, 2020 by Alan Khadavi

How does Dupixent work?

How does Dupixent work?

Dupixent is currently indicated for patients who have atopic dermatitis, asthma and nasal polyps. Dupixent works by inhibiting IL4 and IL13 and it has improved outcomes in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).  A recent study published in Allergy studied Dupixent’s local effects on type 2 inflammatory biomarkers. The study evaluated adults with bilateral nasal polyps who despite intranasal corticosteroid treatment had persistent symptoms including lack of smell.

It was a placebo controlled study and there was a significant decrease of type 2 biomarker concentrations in nasal secretions for those receiving Dupixent (dupilumab).

The results showed that patients who received the dupilumab, their nasal secretions had significant reductions in the following biomarkers.

  • Eosinophil cationic protein chemokine
  • Eotaxin 2
  • Eotaxin-3
  • pulmonary and activation-regulated chemokine
  • IgE

Reductions in local biomarkers were associated with symptom improvements and reduction in polyp mass.  Effective dupilumab therapy for CRSwNP is associated with reduced type 2 inflammatory markers in nasal secretions and polyp tissues.  The benefit of inhibiting IL 4 and IL 13 seems to results from reductions in type 2 inflammation.

This broad mechanism of action of Dupixent gives it an advantage over other atopic disease treatments that only target 1 cytokine or the total IgE only.

The authors of this most recent study previously demonstrated that Dupixent reduced polyp size and sense of smell in patients with CRSwNP.  Now their analysis shows that Dupixent reduced multiple inflammatory biomarkers including total IgE and markers of eosinophilic inflammation, in both nasal secretions and polyp tissue.

Dupilumab for Nasal Polyps

Sinusitis Diagnosis and Management

Xhance for Nasal Polyps

Nasonex OTC coming soon

Dupixent (dupilumab) is the first biological medication indicated for nasal polyps. There sure will be more medications approved in the future that will be approved for nasal polyps.  Dupixent has a broad mechanism of action as shown here which is why it works for different atopic disease states.

Criteria for Dupixent (dupilumab) for Eczema

Filed Under: biologics, Blog, Sinus

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

May 31, 2023

Understanding Yeast Allergy, am I Allergic to Yeast?

yeast allergy

May 23, 2023

Neffy, a New Epinephrine Nasal Spray

neffy

May 19, 2023

Broccoli Allergy: An Emerging Concern in Allergy

broccoli allergy

May 16, 2023

Xolair vs. Nucala vs. Dupixent in Asthma, which is the best?

Xolair vs. Nucala vs. Dupixent

May 10, 2023

Garlic Allergy, An Overview and its Benefits

garlic allergy

May 4, 2023

Oat Allergy: Symptoms, Diagnosis, and Treatment

oat allergy

May 3, 2023

Rice Allergy Overview, all you need to know

rice allergy

April 11, 2023

Banana Allergy Can Come in Many Flavors

banana allergy

April 9, 2023

Eggplant Allergy, an uncommon food allergen

eggplant allergy

April 7, 2023

Corn Allergy: Causes, Symptoms, and Treatment

corn allergy

Read More Posts...

Follow Us…

© 2023 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page